{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:58:39Z","timestamp":1790049519773,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1124\/jpet.110.174433","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T05:29:53Z","timestamp":1312867793000},"page":"567-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preclinical Pharmacology and Pharmacokinetics of AZD3783, a Selective 5-Hydroxytryptamine 1B Receptor Antagonist"],"prefix":"10.1016","volume":"339","author":[{"given":"Minli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diansong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel V.","family":"Widzowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia D.","family":"Sobotka-Briner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky J.","family":"Brockel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok B.","family":"Shenvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Edward","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.174433_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2004.07.067","article-title":"In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine 1B autoreceptor antagonist","volume":"499","author":"Ahlgren","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4088\/JCP.v59n0602","article-title":"Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments","volume":"59","author":"Byrne","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.110.174433_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1007552927404","article-title":"Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans","volume":"17","author":"Chiou","year":"2000","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.110.174433_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuropharm.2006.01.010","volume":"50","author":"Dawson","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.110.174433_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archpsyc.1990.01810170011002","article-title":"Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan","volume":"47","author":"Delgado","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.110.174433_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1016353705970","article-title":"Comparison of canine and human gastrointestinal physiology","volume":"3","author":"Dressman","year":"1986","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.110.174433_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.110.174433_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1749-6632.1998.tb10219.x","article-title":"The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo","volume":"861","author":"Gaster","year":"1998","journal-title":"Ann NY Acad Sci"},{"issue":"3 Suppl B","key":"10.1124\/jpet.110.174433_bib9","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1177\/0269881198012003041","article-title":"Selective serotonin reuptake inhibitors in the treatment of affective disorders. III. Tolerability, safety and pharmacoeconomics","volume":"12","author":"Goldstein","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.110.174433_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2009.03.002","article-title":"Target site occupancy: emerging generalizations from clinical and preclinical studies","volume":"122","author":"Grimwood","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.110.174433_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(97)01055-8","article-title":"Stimulation of 5 HT1B receptors causes hypothermia in the guinea pig","volume":"331","author":"Hagan","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/YCO.0b013e328334bc92","article-title":"The use of SSRIs in children and adolescents","volume":"23","author":"Hetrick","year":"2010","journal-title":"Curr Opin Psychiatry"},{"key":"10.1124\/jpet.110.174433_bib13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.bjp.0702239","article-title":"Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181","volume":"125","author":"Hillegaart","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0091270009333209","article-title":"Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches","volume":"49","author":"Hosea","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.102.045468","article-title":"Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine 1B antagonist","volume":"304","author":"Hudzik","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.174433_bib17","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.110.174433_bib18","series-title":"Handbook of Experimental Pharmacology: Serotoninergic Neurons and 5-HT Receptors in the CNS","first-page":"707","article-title":"Animal models of integrated serotoninergic functions: their predictive value for the clinical applicability of drugs interfering with serotoninergic transmission","author":"Keane","year":"1997"},{"key":"10.1124\/jpet.110.174433_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.109.150722","article-title":"[N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy","volume":"330","author":"Maier","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.174433_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01244621","article-title":"Hypothermia induced by m-trifluoromethylpiperazine or m-chlorophynylpiperazine: an effect mediated by 5-HT1B receptors?","volume":"73","author":"Maj","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.110.174433_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.2000.tb10942.x","article-title":"Antidepressant selection: proceedings from a TCA\/SSRI Consensus Conference","volume":"403","author":"Mendlewicz","year":"2000","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1124\/jpet.110.174433_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2165\/00003495-199652050-00001","article-title":"Drug treatment of depression in the 1990s. An overview of achievements and future possibilities","volume":"52","author":"M\u00f6ller","year":"1996","journal-title":"Drugs"},{"key":"10.1124\/jpet.110.174433_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00581-1","article-title":"The possible role of 5-HT1B\/D receptors in psychiatric disorders and their potential as a target for therapy","volume":"404","author":"Moret","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nucmedbio.2009.10.007","article-title":"High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943","volume":"37","author":"Nabulsi","year":"2010","journal-title":"Nucl Med Biol"},{"issue":"Suppl E1","key":"10.1124\/jpet.110.174433_bib25","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.110.174433_bib26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.174433_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3565(24)36999-X","article-title":"The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data","volume":"283","author":"Obach","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.174433_bib28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jps.2600680948","article-title":"Effect of altered plasma protein binding on apparent volume of distribution","volume":"68","author":"Oie","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.110.174433_bib29","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.neuroimage.2008.02.063","article-title":"[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain","volume":"41","author":"Pierson","year":"2008","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.110.174433_bib30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery","volume":"299","author":"Polli","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.174433_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0361-9230(01)00628-1","article-title":"Ligands for the investigation of 5-HT autoreceptor function","volume":"56","author":"Roberts","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1124\/jpet.110.174433_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1568026023393903","article-title":"Recent advances in 5-HT1B\/1D receptor antagonists and agonists and their potential therapeutic applications","volume":"2","author":"Slassi","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/jpet.110.174433_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00210-004-0866-0","article-title":"Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002","volume":"369","author":"Stenfors","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib34","first-page":"37","article-title":"Medical complications of SSRI and SNRI treatment","volume":"15","author":"Sussman","year":"2008","journal-title":"Primary Psychiatry"},{"key":"10.1124\/jpet.110.174433_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570160033378312","article-title":"Pharmacogenetics of selective serotonin reuptake inhibitor response in major depression","volume":"1","author":"Tsai","year":"2003","journal-title":"Curr Pharmacogenomics"},{"key":"10.1124\/jpet.110.174433_bib36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-011-2165-z","article-title":"Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369","volume":"213","author":"Varn\u00e4s","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.110.174433_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(96)00579-1","article-title":"GR127935 acts as a partial agonist at recombinant human 5-HT1D\u03b1 and 5-HT1D\u03b2 receptors","volume":"314","author":"Watson","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.174433_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0028-3908(97)00023-3","article-title":"Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors","volume":"36","author":"Zgombick","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.110.174433_bib39","first-page":"147","article-title":"In vitro metabolism of AZ12320927: metabolite profiling in human, rat, dog, guinea pig, mouse and rabbit hepatocytes and enzymes identification in human liver microsomes","volume":"3","author":"Zhou","year":"2008","journal-title":"Drug Metab Rev"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652446624X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652446624X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.174433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:48:50Z","timestamp":1743202130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652446624X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S002235652446624X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.174433","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Pharmacology and Pharmacokinetics of AZD3783, a Selective 5-Hydroxytryptamine 1B Receptor Antagonist","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.174433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}